PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Borg, D.J.* ; Bonifacio, E.*

The use of biomaterials in islet transplantation.

Curr. Diab. Rep. 11, 434-444 (2011)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Pancreatic islet transplantation is a therapeutic option to replace destroyed β cells in autoimmune diabetes. Islets are transplanted into the liver via the portal vein; however, inflammation, the required immunosuppression, and lack of vasculature decrease early islet viability and function. Therefore, the use of accessory therapy and biomaterials to protect islets and improve islet function has definite therapeutic potential. Here we review the application of niche accessory cells and factors, as well as the use of biomaterials as carriers or capsules, for pancreatic islet transplantation.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
0.000
0.646
45
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2011
HGF-reported in Year 0
ISSN (print) / ISBN 1534-4827
e-ISSN 1539-0829
Journal Current Diabetes Reports
Quellenangaben Volume: 11, Issue: 5, Pages: 434-444 Article Number: , Supplement: ,
Publisher Springer
Publishing Place Heidelberg [u.a.]
Reviewing status Peer reviewed
Institute(s) Institute of Pancreatic Islet Research (IPI)
PubMed ID 21748257
DOI 10.1007/s11892-011-0210-2
Erfassungsdatum 2011-12-31
[➜Report correction]